BioSpace News Archive

China Biologic Products Holdings, Inc. (NASDAQ: CBPO, “China Biologic” or the “Company”), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that its board of directors (the “Board”) has received a preliminary non-binding proposal letter

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will host a webcast on Wednesday, September 25, 2019 at 9:00 p.m. EDT/2:00 a.m. IST (September 26, 2019) to provide investors with a business update, including data being presented on JZP-258 and solriamfetol at the World Sleep Congress, to be held in Vancouver, B.C. September 20-25, 2019.

First FDA Approved Trifocal Lens Allows Cataract Patients to See Clearly

Healthcare technology company receives NIH funding for low dose MRI exams

Long-Term Follow-up Data Show That the 88% of Patients Treated in the Starbeam Study (ALD-102) Were Free of Major Functional Disabilities (MFDs) at Two Years, and Continued to Remain MFD-Free at up to Five Years of Follow-up

Densitas densityai™ delivers fully automated, standardized, and reproducible breast density assessments from standard DICOM clinical use mammograms.

Spectral Medical Inc. commenced trading on Toronto Stock Exchange on June 6, 1994.

Innovative platform seeks to further empower the work of speech-language pathologists

September is Polycystic Ovary Syndrome (PCOS) Awareness Month and this weekend, Friday, September 20th through Sunday, September 22nd, advocates, supporters, healthcare providers, and corporate and community leaders are joining PCOS Challenge: The National Polycystic Ovary Syndrome Association to launch a key PCOS awareness effort in Orlando, Florida

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, announces its financial results for the six-month period ended June 30, 2019, and provides an update on its portfolio.